ADDICTION AND THE EVOLUTION AND COMPLIANCE OF SCHIZOPHRENIC PATIENTS

Introduction Schizophrenia is a chronic illness, affecting approximately 1% of the general population. The more treatment is, poorer quality adherence. In fact, 60% patients with schizophrenia are incompletely or non-adherent within one year first episode. Poor adherence has consequences in terms clinical status, life and psychosocial functioning due to associated relapses. One main factors poor compliance use addictive substances. Half schizophrenic have, have had, an comorbidity during their life. Moreover, severe symptomatology physical, psychological social problems, representing challenge management Objectives objective our work evaluate impact on medication relapse. Methods This cross-sectional study, carried out hospitalized followed ambulatory consultation, at psychiatric hospital Ar-razi Salé. data collection (sociodemographic, therapeutic) by questionnaire established for this purpose. substances evaluated according DSM-V criteria Results A total 110 were hospitalized, which 61.8% had substance disorder. average age onset was 18 years. duration ranged from 1 11 years up 49 tobacco cannabis. 72% addicts tried stop alone outpatient settings, only 17% inpatient settings. abstinence months 81% reported remission disease after abstinence. hospitalization rate 88.2% versus 85% non-addicts. number hospitalizations 180 78 cumulative 208 against 96 addicts. 5 24 71% non-addicts well observed 57% Conclusions weight co-morbid addictions represents between 1/5 1/3 stake risk relapse suffering schizophrenia. development specific care strategies global addiction should be priority. Disclosure Interest None Declared